β-alanine and α-fluoro-β-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 1 39-1, 1999, Pages

  Liu, Mengping ^a   Russell, Rosalind L ^a   Beigelman, Leonid ^b   Handschumacher, Robert E ^a   Pizzorno, Giuseppe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sirna Therapeutics Inc   (United States)

Author keywords

5 fluorouracil; Liver; Uridine

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA FLUORO BETA ALANINE; BETA ALANINE; CARRIER PROTEIN; FLUOROURACIL; URACIL;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; LIVER CELL MEMBRANE; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

EID: 0032895265     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.1.g206     Document Type: Article

References (25)

1. Ahn, A., O. Mundigl, T. R. Muth, G. Rudnick, and M. J. Caplan. Polarized expression of GABA transporters in Madin-Darby canine kidney cells and cultured hippocampal neurons. J. Biol. Chem. 271: 6917-6924, 1996.
2. Berry, M. N., and D. S. Friend. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J. Cell Biol. 43: 506-520, 1969.
3. Borden, L. A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29: 335-356, 1996.
4. Borden, L. A., K. E. Smith, P. R. Hartig, T. A. Branchek, and R. L. Weinshank. Molecular heterogeneity of the γ-aminobutyric acid (GABA) transport system. J. Biol. Chem. 267: 21098-21104, 1992.
5. +-dependent carrier on the basolateral plasma membrane. Am. J. Physiol. 253 (Gastrointest. Liver Physiol. 16): G351-G358, 1987.
6. Darnowski, J. W., and R. E. Handschumacher. Tissue uridine pools: evidence in vivo of a concentrative mechanism for uridine uptake. Cancer Res. 46: 3490-3494, 1986.
7. Davis, B. J. Disc electrophoresis II. Method and application to human serum proteins. Ann. NY Acad. Sci. 121: 404-427, 1964.
8. Hardison, W. G. M., and R. Weiner. Taurine transport by rat hepatocytes in primary culture. Biochim. Biophys. Acta 598: 145-152, 1980.
9. Holopainen, I., and P. Kontro. High-affinity uptake of taurine and β-alanine in primary cultures of rat astrocytes. Neurochem. Res. 11: 207-215, 1986.
10. Jessen, H. Taurine and β-alanine transport in an established human kidney cell line derived from the proximal tubule. Biochim. Biophys. Acta 1194: 44-52, 1994.
11. Jessen, H., and M. I. Sheikh. Stoichiometric studies of β-alanine transporters in rabbit proximal tubule. Biochem. J. 277: 891-894, 1991.
12. Jones, D. P., L. A. Miller, and R. W. Chesney. Polarity of taurine transport in cultured renal epithelial cell lines LLPK and MDCK. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F137-F145, 1993.
13. Laemmli, U. K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 277: 680-683, 1970.
14. Larsson, O. M., R. Griffiths, I. C. Allen, and A. Schousboe. Mutual inhibition kinetic analysis of γ-aminobutyric acid, taurine, and β-alanine high-affinity transport into neurons and astrocytes: evidence for similarity between the taurine and β-alanine carriers in both cell types. J. Neurochem. 47: 426-432, 1986.
15. Liu, M.-P., L. Beigelman, E. Levy, E. R. Handschumacher, and G. Pizzorno. The discrete roles of hepatocytes and nonparenchymal cells in uridine catabolism as a component of uridine homeostasis. Am. J. Physiol. 274 (Gastrointest. Liver Physiol. 37): G1018-G1023, 1998.
16. Miyamoto, Y., H. Kakamura, T. Hoshi, V. Ganapathy, and F. H. Leibach. Uphill transport of β-alanine in intestinal brush-border membrane vesicles. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G372-G379, 1990.
17. Moertel, C. G., R. J. Reitemeier, C. F. Bolton, and R. G. Shorter. Cerebellar ataxia associated with fluorinated pyrimidine therapy. Cancer Chemother. Rep. 41: 15-18, 1964.
18. Okeda, R., M. Shibutani, T. Matsuo, T. Kuroiwa, R. Shimokawa, and T. Tajima. Experimental neurotoxicity of 5-fluorouracil and its derivatives due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and α-fluoro-β-alanine. Acta Neuropathol. (Berl.) 81: 66-73, 1990.
19. Ornstein, L. Disc electrophoresis I. Background and theory. Ann. NY Acad. Sci. 121: 321-349, 1964.
20. Riehl, J. B., and W. J. Brown. Acute cerebellar syndrome secondary to 5-FU therapy. Neurology 14: 961-967, 1964.
21. Smedsrod, B., and H. Pertoft. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J. Leukoc. Biol. 38: 213-230, 1985.
22. Sommadossi, J.-P., D. A. Gewirtz, R. B. Diasio, C. Aubert, J.-P. Cano, and I. D. Goldman. Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J. Biol. Chem. 257: 8171-8176, 1982.
23. Turner, R. J. β-Amino acid transport across the renal brush border membrane is coupled to both Na and Cl. J. Biol. Chem. 261: 16060-16066, 1986.
24. Yeh, K. H., and A. L. Cheng. High-dose 5-fluorouracil infusional therapy is associated with hyperammoneamia, lactic acidosis and encephalopathy. Br. J. Cancer 75: 464-465, 1997.
25. Zhang, R., S.-J. Soong, T. Liu, S. Barnes, and R. B. Diasio Pharmacokinetics and tissue distribution of 2-fluoro-β-alanine in rats potential relevance to toxicity pattern of 5-fluorouracil. Drug Metab. Dispos. 20: 113-119, 1992.